 production response human type stimulation patients systemic sclerosis Peripheral blood mononuclear cells PBMC patients systemic sclerosis SSc increased amounts dose-dependent manner response stimulation human type whereas PBMC normal subjects dose micrograms human type PBMC PBMC SSc patients times much PBMC normal subjects times much PBMC group rheumatoid arthritis patients contrast production PBMC nonspecific stimulation mitogen phytohemagglutinin SSc rheumatoid arthritis normal control groups Cell depletion experiments cells SSc patients Thus SSc patients cells human type increased levels Measurement production human type useful disease activity investigation process delineation pathogenesis SSc